U.S. imports of Medicaments Containing Pseudoephedrine or Its Salts, in Measured Doses for Retail Sale (HS 300442) totaled $2.1M in September 2026, imported from 5 countries.
Medicaments Containing Pseudoephedrine or Its Salts, in Measured Doses for Retail Sale imports of $2.1M in September 2026 ran 14% above the year-to-date monthly average of $1.8M.
Last updated: September 2026 dataPseudoephedrine-containing finished-dose medicaments — widely recognized in trade as decongestant products — are classified under a single US tariff line, 3004420000, covering both mixed and unmixed formulations. Like ephedrine, pseudoephedrine is a DEA-regulated listed chemical, so importers must secure DEA import authorization and comply with quota allocations in addition to meeting FDA drug establishment and labeling requirements. The retail-sale packaging requirement is a key classification criterion: bulk pseudoephedrine API moves under a different chapter entirely. Importers should be aware that domestic retail sale of pseudoephedrine products is further regulated under the Combat Methamphetamine Epidemic Act, which affects downstream distribution planning.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
19 import shipments a month
Yes. Heading 300442 applies only to finished-dose forms put up in measured doses or packaged for retail sale. Bulk pseudoephedrine active pharmaceutical ingredient (API) is classified in Chapter 29 as an organic chemical, not in Chapter 30, and carries different regulatory and tariff treatment.
Importers must present FDA drug establishment registration for the foreign manufacturer, a DEA import permit or quota authorization, and standard entry documentation. FDA may detain shipments for examination if the establishment is not on the approved list or if labeling is non-compliant. Consult a licensed customs broker familiar with pharmaceutical imports to ensure all DEA and FDA requirements are met prior to shipment.
Trade Directory
List your company under HS 300442 — Medicaments Containing Pseudoephedrine or Its Salts, in Measured Doses for Retail Sale, so the companies trading it can find you. Be the first supplier listed.
Subheading 10 of 12 in heading 3004
Subheading 300442 · $2.1M of $7.1B
ImportsExports
Imports
$2.1MYoY · free account
Exports
—YoY · free account
12-mo low · imports
Low · free accountOver the twelve months to September 2026, the U.S. imported $21.3M of Medicaments Containing Pseudoephedrine or Its Salts, in Measured Doses for Retail Sale.
Through September 2026 · exports 11 of 12 months reported. Source: U.S. Census Bureau.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Imports for consumption | Average duty rate | Dutiable Share |
|---|---|---|---|---|
| 3004420000 | Medicaments(Mixed/Unmixed)Cnt Pseudoephedrine/Salt | $1.5M | 0.00% | 0.00% |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3004420000 | Medicaments(Mixed/Unmixed)Cnt Pseudoephedrine/Salt | $1.4M |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
Imports · September 2026
origin
France and Canada together supply 95% of it.
customs district
destination
entry
rate provision · imports
100.0% enters free of duty; duty collected equals 0.00% of imports for consumption.